SOCIAL_HF: Improving Social Frailty Through Interactive Learning
NCT07234565
Summary
The goal of this clinical trial is to learn whether the WeChat-based program "Social Optimization Chat for Interactive Learning for Heart Failure" (SOCIAL\_HF) can improve social frailty in elderly patients with heart failure. The main questions it aims to answer are: Can a 6-week WeChat online group interactive learning program (SOCIAL\_HF) improve social frailty? Does the intervention enhance self-care abilities, social participation, and perceived social support? Researchers will compare SOCIAL\_HF to usual care (self-study heart failure self-care manual) to assess whether SOCIAL\_HF can improve social functioning. Participants will: Engage in weekly WeChat video meetings for six weeks (Participate in peer sharing and collaborative tasks). Complete daily health task check-ins. Access online self-care resources.
Eligibility
Inclusion Criteria: 1. 60 years old and above; 2. Live in the community; 3. a definitive diagnosis of heart failure based on the Framingham Heart Failure Diagnostic Criteria; 4. a diagnosis of heart failure for 6 months or longer; 5. evidence of social pre-frailty or frailty, determined by the SFS-8 score ≥ 2; (6) possession of a smartphone and experience using WeChat; (7) be able to read and write Chinese. Exclusion Criteria: 1. severe cognitive impairment or dementia; 2. known mental illnesses; 3. any communication barriers may hinder participation in SOCIAL\_HF, such as illiteracy, reading disabilities, speak local dialect only, and difficulties in language comprehension; 4. any sensory impairments that may affect learning or interaction with others on WeChat, including untreated severe hearing loss and vision impairments; 5. are currently participating in other intervention studies.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07234565